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Unique Solution for an Urgent Need
• Current challenge in Kymriah manufacturing for 
adult cell therapy seems to be the lower viability 
of CAR-T cells during cell expansion in bioreactor.
• This problem can be easily solved by a BioSettler, 
which can selectively remove the dead cells and 
cell debris from the expanding cell suspension.
• BioSettler technology, selective removal of dead 
cells and recycle of live cells, has been proven with 
mammalian cells in large perfusion bioreactors.
• Now this technology is available as single use 
disposable plastic BioSettlers for autologous cell 
therapy manufacturing applications.
Inclined Settler – a selective cell retention device
• Simple, passive, robust & powerful technology
• Uses no membrane barriers that can clog!
• Uses no moving parts that can break down!
• Proven at large scale for mammalian cell cultures
• Selective removal of dead cells and cell debris
• Complete recycle of live cells to bioreactor
• High viable cell density and productivity
• Perfusion bioreactors can be operated indefinitely








Inclined Settler as a selective cell retention device 
Batt, Davis & Kompala, Biotech Prog, 6:458-464,1990;
Searles, Todd & Kompala, Biotech Prog, 10:198-206,1994
Inclined settler scaled up for a 3000 L perfusion bioreactor (replacing n-1 seed train)
Pohlscheidt, et al. Biotech Prog. (2013)29:222-229, Roche/Genentech, Germany
Novel Compact Cell Settlers
Easily scalable cylindrical & conical design
6 – 10 x more settling area for the same footprint
6” diameter Compact Cell Settler attached 
to a 1.2-liter Celligen CHO Cell Bioreactor
Perfusion Bioreactor of CHO cells with our Novel 

















































Selective Removal of Smaller Dead Cells & 
Cell Debris in BioSettler Top Effluent
Multisizer 4e  4.03
Page 2




















Number Statistics (Arithmetic) 170422_brx_d5.#m4





95% Conf. Limits: 5.888-6.009 µm
S.D.: 5.72 µm
d10: 2.325 µm d50: 3.169 µm d90: 16.64 µm
Number Statistics (Arithmetic) 170422_eff_d5.#m4





95% Conf. Limits: 4.569-4.654 µm
S.D.: 2.75 µm




-------- Cell Debris -------
Bioreactor sample
Settler Top Effluent
Single Use Disposable BioSettler 150 
developed with NIIMBL funding
BioSettler for 1. CHO Perfusion Bioreactor
CHO Cell Density profiles from our first  































































Culture Duration (Days) 
Return VCD
VCD Bioreactor
Dead cell Conc in Return
Dead Cell Conc in Bioreactor
Dead cell conc in Effluent
Effluent VCD
Effluent rate (mL/day)
Cell Viability profiles during our first 



























































Size distribution of cells in samples from 
Bioreactor, Settler Effluent & Return
Multisizer 4e  4.03
Page 2
20 Jun 2017  12:08
Multisizer 4e data: C:\Multisizer4e\Calibration\Sudhin\Bioreactor\run 10\ret\170613_ret_d11.#m4





Electrolyte: BCI ISOTON II
Dispersant: None
Aperture: 100 µm Kd: 126.01
Aperture current: 600 µA Preamp gain: 4
Size bins: 400 from 2 µm to 60 µm, log diameter
Total count: 34690    (Coincidence corrected)
Count > 2 µm: 30278 Coincidence corrected:   35072
Coincidence correction: 15.8%
Control mode: Total count 30000 
Elapsed time: 18.78 seconds
Acquired:  9:49  13 Jun 2017
Electrolyte volume: 9.98 mL





























2. Clarification of Cell Culture Broth in the 
BioSettler150 at Sudhin Biopharma
Reducing culture broth’s pH from 7 to 5 or lower 
by adding a small amount of acetic or citric acid 
causes cell clumping and rapid settling of clumps.
Fast settling cell clumps may be removed from 
the bottom port with a peristaltic pump quickly 
before they get packed or compacted.  After 
draining out the cell clumps, the clarified 
supernatant can be collected via bottom port.
Alternately, the secreted product in the settling 
cell clumps may be removed by pumping in a 
buffer via bottom port to wash out the product 
from these cell clumps and collecting the diluted 
and clarified supernatant from the top port.
This photograph shows the collected cell clumps 
(~70 ml) at the bottom of settler from 3.5 liters of 
cell culture broth at 2 – 4 million cells/ml plus 
about 300 ml of acetic acid at pH 4.
2a. Washing of Settled Cell Clumps
2b. Draining of Cell Clumps from bottom
2c. Fed-Batch Cell Clump & Clarification
3.4 liters of cell culture broth (pH 7) were pumped with 
about 400 ml of citric acid (pH 4) in to fill the settler (3.8 
liters) over 30 minutes and reduce the pH to below 6.
More cell culture broth (4.6 liters) and citric acid (600 ml) 
were pumped in at a lower rate over the next 3 hours, as 
the clarified supernatant is collected at 1.8 liters/hr from 
the top port.
Total of 8 liters of cell culture broth was pumped in the 
settler along with 1 liter of citric acid and was clarified in 
< 4 hours while the cell clumps were retained in the 
single use disposable biosettler.
91.4% of secreted antibody product was recovered in the 
settler clarified supernatant, plus an additional 7.3% of 
IgG was recovered after centrifuging the cell clumps.
Centrifugation of the clarified supernatant resulted in a 
packed cell volume (PCV) of 0.5%, whereas the PCV in the 
starting cell culture broth was 3.0% (reduction of 83.3 %).
3. Affinity Capture of Secreted Antibodies 
on Protein A beads suspended in settler
• Protein A beads (GE MabSelect SuRe LX) have a size 
range of 28 – 82 microns(m), with a median of 43 m.
• Size range of live CHO cells is  10-20 m, dead cells: 8 –
10m, and cell debris: < 8m.
• Cell culture broth from end of Fed-batch bioreactor can 
be directly loaded into our settler, along with Protein A 
beads.
• After secreted antibodies are bound to the larger beads 
suspended in the settler, all smaller cells, debris and 
unbound host cell proteins can be washed out the top.  
• Elution and regeneration steps can also be carried out 
sequentially with the beads suspended in the settler. 
3. Affinity Capture Experimental Setup
Sudhin BioSettler for Cell Therapy Applications
Selective Removal of Dead Cells and Cell Debris to increase 
viability percentage in expanded CAR-T cells (e.g. Kymriah)
Harvesting, Washing and Concentration of many in vitro 
expanded cells in a closed, bench-top automated device.
Harvesting and Purification of ex vivo expanded MSCs after 
expansion on microcarriers and enzymatic detachment.
Harvesting of Organoids, such as the larger b cell islets, 
from smaller iPSCs and other differentiating cells.
Harvesting of Gene Therapy vectors (AAV) from HEK cells 
(being tested at NCState Univ through a NIIMBL SP grant).
Clarification of Cell Culture Broth from fed-batch culture 
(being tested at Genentech through NIIMBL QSP grant).
Selective Cell Retention Device for achieving high cell 
densities and viabilities in perfusion bioreactors (Sudhin).
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